AI firm Aiforia and Mayo Clinic have exclusively licensed an AI model to improve prediction of colorectal cancer recurrence. The model analyses digitised tissue samples and combines this with clinical parameters to provide a personalised risk score. It will aid informed treatment decisions, potentially reducing unnecessary chemotherapy and better targeting high-risk patients to improve long-term outcomes. The Aiforia-Mayo Clinic collaboration also underlines a commitment to personalized medicine and continuous innovation.
Brazilian Man Accused of Threatening to Release Stolen Data Gained Through Illegal Computer Breach – DataBreaches.Net
Alright, then. Are you sitting comfortably? Let me spin you a tale about Junior Barros De Oliveira, a 29-year-old lad from Curitiba in Brazil. Now,
